17 May 2018 EMA/333504/2018 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance(s): dornase alpha

Procedure No.: PSUSA/00001164/201709

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product name (in authorisation country) Pulmozyme 1 mg/ml (2500 E/2,5 ml), lösning för nebulisator Pulmozyme 1 mg/ml inhalasjonsvæske til nebulisator, oppløsning Pulmozyme 1 mg/ml lösning för nebulisator Pulmozyme 1 mg/ml sumutinliuos Pulmozyme 1 mg/ml, lausn fyrir eimgjafa PULMOZYME 2 500 U/2,5 ml roztok k inhalaci Pulmozyme 2 500 U/2,5 ml Roztok na rozprašovanie Pulmozyme 2,5 mg inhalacijska raztopina za nebulator Pulmozyme 2,5 mg oldat porlasztásra PULMOZYME 2.500 E./2,5 ml – Lösung für einen Vernebler Pulmozyme 2.500 U/2,5 ml solución para inhalación por nebulizador Pulmozyme 2500 E/ 2,5 ml verneveloplossing Pulmozyme 2500 E/2,5 ml, verneveloplossing Pulmozyme 2500 TV/2,5 ml purškiamasis įkvepiamasis tirpalas Pulmozyme 2500 U / 2,5 ml, solu テァテ」o para inala テァテ」o por nebuliza テァテ」o Pulmozyme 2500 U/ 2.5 ml, nebuliser solution

MRP/DCP Authorisation number UK/H/0060/001

National Authorisation Number 11899

MAH of product in the member state ROCHE AB

Member State where product is authorised SE

not available

8057

F. HOFFMANN-LA ROCHE AG

NO

UK/H/0060/001

11681

ROCHE OY

FI

UK/H/0060/001

11681

ROCHE OY

FI

not available

930291

ROCHE A/S

IS

not available

52/270/95-C

ROCHE S. R. O.

CZ

not available

52/0392/97-S

ROCHE SLOVENSKO S.R.O.

SK

not available

H/98/01306/001

ROCHE FARMACEVTSKA DRUŽBA D.O.O.

SI

not available

OGYI-T-4562/01

HU

UK/H/0060/001

1-20192

ROCHE (MAGYARORSZÁG) KFT ROCHE AUSTRIA GMBH

UK/H/0060/001

60.326

ROCHE FARMA, S.A.

ES

UK/H/0060/001

BE167002

N.V. ROCHE S.A.

BE

UK/H/0060/001

RVG 16734

ROCHE NEDERLAND B.V.

NL

not available

LT/1/96/1470/001

UAB "ROCHE LIETUVA"

LT

UK/H/0060/001

2231488

ROCHE FARMACÊUTICA QUÍMICA, LDA.

PT

not available

MA 060/00901

ROCHE PRODUCTS LTD

MT

List of nationally authorised medicinal products EMA/333504/2018

AT

Page 2/4

Product name (in authorisation country) Pulmozyme 2500 U/ 2.5 ml, nebuliser solution Pulmozyme 2500 U/2,5 ml otopina za atomizator Pulmozyme 2500 U/2,5 ml soluţie de inhalat prin nebulizator Pulmozyme 2500 U/2,5 ml solution pour inhalation par nébuliseur Pulmozyme 2500 U/2,5 ml solution pour inhalation par nébuliseur Pulmozyme 2500 U/2,5 ml, solution pour inhalation par nébuliseur Pulmozyme 2500 U/2,5 ml, solution pour inhalation par nébuliseur Pulmozyme 2500 U/2,5 ml, soluzione per nebulizzatore Pulmozyme 2500 U/2.5ml, διάλυμα για εισπνοή μέσω εκνεφωτή Pulmozyme 2500 V/2,5 ml šķīdums izsmidzināšanai PulmozymeÒ Nebulizersolution 2500 U (2.5mg)/2.5ml corresponding to 1000 U/ml Pulmozyme, 1 mg/ml, roztwór do nebulizacji Pulmozyme, 2500 ühikut/2,5 ml nebuliseeritav lahus

MRP/DCP Authorisation number UK/H/0060/001

National Authorisation Number PL 00031/0335

MAH of product in the member state ROCHE PRODUCTS LTD

Member State where product is authorised UK

not available

HR-H-587894223

ROCHE D.O.O.

HR

not available

6524/2014/01

ROCHE ROMANIA SRL

RO

UK/H/0060/001

BE167002

N.V. ROCHE S.A.

BE

UK-H-60

0178/09060393

N.V. ROCHE S.A.

LU

UK/H/0060/001

3400936467545

ROCHE

FR

UK/H/0060/001

3400936467484

ROCHE

FR

UK/H/0060/001

029352010

ROCHE S.P.A.

IT

UK/H/0060/001

78409/16/22.06.2017

ROCHE (HELLAS) SA

GR

not available

99-0403

ROCHE LATVIJA SIA

LV

UK/H/0060/001

2231389

ROCHE FARMACÊUTICA QUÍMICA, LDA.

PT

not available

R/3758

ROCHE POLSKA SP.O.O.

PL

not available

142996

ROCHE EESTI OÜ

EE

List of nationally authorised medicinal products EMA/333504/2018

Page 3/4

Product name (in authorisation country) Pulmozyme, inhalationsvæske til nebulisator, opløsning Pulmozyme® 2.500 E./2,5 ml, Lösung für einen Vernebler Пулмозим 2500 U (2,5 mg)/ 2,5 ml разтвор за небулизатор

MRP/DCP Authorisation number UK/H/0060/001

National Authorisation Number 15462

MAH of product in the member state ROCHE A/S

Member State where product is authorised DK

UK/H/0060/001

30289.00.00

ROCHE PHARMA AG

DE

not available

9600090

ROCHE BULGARIA EOOD

BG

List of nationally authorised medicinal products EMA/333504/2018

Page 4/4

PSUSA/00001164/201709 - European Medicines Agency - Europa EU

May 17, 2018 - solution pour inhalation par nébuliseur. UK/H/0060/001. 3400936467484. ROCHE. FR. Pulmozyme 2500 U/2,5 ml, soluzione per nebulizzatore.

124KB Sizes 98 Downloads 160 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...